[-] Show simple item record

dc.contributor.authorHecox, Kerrieng
dc.contributor.authorHale, Wayne A.eng
dc.contributor.authorMackler, Leslieeng
dc.date.issued2004eng
dc.description.abstractThere is insufficient evidence to advocate the routine use of folate supplementation for the treatment of coronary artery disease (CAD). High levels of serum homocysteine have been associated in several studies with an increased risk for CAD (strength of recommendation [SOR]: B, associated in case-control studies). Folate supplementation decreases the level of serum homocysteine (SOR: A, meta-analysis of randomized controlled trials). This indirect evidence suggests that folate supplementation may be of benefit in slowing the progress of arteriosclerosis.eng
dc.identifier.urihttp://hdl.handle.net/10355/3183eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2004 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 53, no. 01 (January 2004): 61-63.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectstatin therapyeng
dc.subjectserum homocysteineeng
dc.subjectcoronary artery diseaseeng
dc.subject.lcshCoronary heart diseaseeng
dc.subject.lcshStatins (Cardiovascular agents)eng
dc.subject.lcshFolic acideng
dc.subject.lcshArteriosclerosiseng
dc.titleIs folate supplementation indicated for patients with CAD?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record